Steris | STE - Loan Capital


Steris reported $1.65B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
3M USD 10.9B 2M Jun/2026
Accuray USD 124.78M 2.54M Dec/2025
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
CONMED USD 657.05M 203.11M Jun/2026
Cooper Companies USD 1.92B 54.8M Jun/2026
Dexcom USD 1.3B 200K Jun/2026
Ecolab USD 11.91B 4.98B Jun/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Fortive USD 3.51B 920M Jun/2026
Getinge SEK 9.09B 167M Jun/2026
Globus Medical USD 398K 38K Mar/2026
Haemonetics USD 1.17B 50.36M Jun/2026
Idexx Laboratories USD 299.86M 11K Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 929.5M 0 Jun/2026
Integra LifeSciences USD 1.83B 2.05M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 37.34B 183M Jun/2026
Olympus JPY 179.76B 20.07B Jun/2026
Orthofix International USD 221.59M 256K Jun/2026
Owens Minor USD 1.8B 35.38M Dec/2025
ResMed USD 399.42M 4.75M Jun/2026
Steris USD 1.65B 162.6M Jun/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 809K Jun/2026
Teleflex USD 2.72B 206.24M Jun/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
Zimmer Biomet Holdings USD 6.28B 17.6M Jun/2026